Overview
Torsten Kleffmann practices practicing medicine in Dunedin, New Zealand.
His clinical expertise encompasses Chronic Fatigue Syndrome, Mononucleosis, and Fibromyalgia.
He is actively involved in clinical research, co-authoring 55 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Torsten Kleffmann
Is Torsten Kleffmann a top-rated expert for Chronic Fatigue Syndrome?
MediFind is an objective health platform that identifies experts based on real-world data. Torsten Kleffmann is classified as an Experienced expert for Chronic Fatigue Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Torsten Kleffmann participate in research or clinical trials?
Yes. Torsten Kleffmann has published 55 articles and abstracts on conditions like Chronic Fatigue Syndrome. You can view a list of Torsten Kleffmann's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Chronic Fatigue SyndromeMr. Kleffmann isExperienced. Learn about Chronic Fatigue Syndrome.
- FibromyalgiaMr. Kleffmann isExperienced. Learn about Fibromyalgia.
- MononucleosisMr. Kleffmann isExperienced. Learn about Mononucleosis.